PLASMA LEVELS OF PLASMINOGEN ACTIVATOR INHIBITOR-1 IN PATIENTS WITH TYPE 2 DIABETES AFTER LIPOPOLYSACCHARIDE INJECTION

被引：0

作者：

Berg, R. M. G. ^{[1
]}

Andreasen, A. S. ^{[1
]}

Pedersen, B. K. ^{[1
]}

Moller, K. ^{[1
,2
]}

机构：

[1] Univ Copenhagen Hosp, Rigshosp, Ctr Inflammat & Metab, Dept Infect Dis, DK-2100 Copenhagen, Denmark

[2] Univ Copenhagen Hosp, Rigshosp, Intens Care Unit 4131, DK-2100 Copenhagen, Denmark

来源：

INTENSIVE CARE MEDICINE | 2009年 / 35卷

关键词：

D O I：

暂无

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

0947

引用

页码：244 / 244

页数：1

共 50 条

[1] Simvastatin reduces plasma levels of plasminogen activator inhibitor-1 in patients with type 2 diabetes mellitus
Dharmalingam, S
Ludwig, S
Ren, S
Fenton, JW
Velthuis, HTE
Shen, G
DIABETES, 2001, 50 : A457 - A457
[2] Plasminogen activator inhibitor-1 and thrombin activable fibrinolysis inhibitor in patients with type 2 diabetes
Blaszkowski, A.
Galar, M.
Sokolowski, J.
Kloczko, J.
DIABETOLOGIA, 2010, 53
[3] Plasminogen activator inhibitor-1 is increased in type 1 diabetes patients with hypertension
Zheng, DY
Hunter, SJ
Lackland, DT
Garvey, WT
Klein, RL
DIABETES, 1999, 48 : A43 - A43
[4] Progression of plasminogen activator inhibitor-1 and fibrinogen levels in relation to incident type 2 diabetes
Festa, A
Williams, K
Tracy, RP
Wagenknecht, LE
Haffner, SM
CIRCULATION, 2006, 113 (14) : 1753 - 1759
[5] Empagliflozin decreases plasma concentrations of plasminogen activator inhibitor-1 (PAI-1) in patients with type 2 diabetes
Aso, Y.
Sakurai, S.
Jojima, T.
Iijima, T.
Usui, I.
DIABETOLOGIA, 2019, 62 : S357 - S357
[6] Effects of gemfibrozil and ciprofibrate on plasma levels of tissue-type plasminogen activator, plasminogen activator inhibitor-1 and fibrinogen in hyperlipidaemic patients
Kockx, M
deMaat, MPM
Knipscheer, HC
Kastelein, JJP
Kluft, C
Princen, HMG
Kooistra, T
THROMBOSIS AND HAEMOSTASIS, 1997, 78 (04) : 1167 - 1172
[7] Plasma tissue plasminogen activator and plasminogen activator inhibitor-1 levels in acute myocardial infarction
Ganti, AK
Potti, A
Yegnanarayan, R
PATHOPHYSIOLOGY OF HAEMOSTASIS AND THROMBOSIS, 2002, 32 (02) : 80 - 84
[8] Plasminogen activator inhibitor-1 and tissue-plasminogen activator in minority adolescents with type 2 diabetes and obesity
Umpaichitra, V
Hussain, MM
Castells, S
PEDIATRIC RESEARCH, 2005, 58 (03) : 483 - 487
[9] Plasminogen Activator Inhibitor-1 and Tissue-Plasminogen Activator in Minority Adolescents with Type 2 Diabetes and Obesity
Vatcharapan Umpaichitra
M Mahmood Hussain
Salvador Castells
Pediatric Research, 2005, 58 : 483 - 487
[10] Plasma level of plasminogen activator inhibitor-1 in patients with MS
Onodera, H
Fujihara, K
Nakashima, I
Itoyama, Y
NEUROLOGY, 1999, 52 (06) : A492 - A492

← 1 2 3 4 5 →